ABSOLUTE LYMPHOCYTE COUNT RECOVERY AS PROGNOSTIC MARKER OF SURVIVAL IN PEDIATRIC PRECURSOR B ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Asim, Muhammad [1 ]
Naithani, Rahul [1 ]
Abdelhaleem, Mohamed [1 ]
Punnett, Angela [1 ]
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1029 / 1029
页数：1
相关论文
共 50 条
  • [21] Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia
    Nina Rolf
    Kinga K. Smolen
    Amina Kariminia
    Adam Velenosi
    Mario Fidanza
    Caron Strahlendorf
    Alix E. Seif
    Gregor S. D. Reid
    Cancer Immunology, Immunotherapy, 2018, 67 : 225 - 236
  • [22] Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia
    Rolf, Nina
    Smolen, Kinga K.
    Kariminia, Amina
    Velenosi, Adam
    Fidanza, Mario
    Strahlendorf, Caron
    Seif, Alix E.
    Reid, Gregor S. D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (02) : 225 - 236
  • [23] Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia
    Troeger, Anja
    Siepermann, Meinolf
    Escherich, Gabriele
    Meisel, Roland
    Willers, Reinhardt
    Gudowius, Sonja
    Moritz, Thomas
    Laws, Hans-Juergen
    Hanenberg, Helmut
    Goebel, Ulrich
    Janka-Schaub, Gritta E.
    Mahotka, Csaba
    Dilloo, Dagmar
    HAEMATOLOGICA, 2007, 92 (08) : 1043 - 1050
  • [24] PROGNOSTIC SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE IN PEDIATRIC PRECURSOR-B ACUTE LYMPHOBLASTIC LEUKEMIA
    Kamel, A.
    El-Sharkawy, N.
    Kandeel, E.
    Moussa, H. S.
    El-Haddad, A.
    HAEMATOLOGICA, 2012, 97 : 483 - 483
  • [25] Association of absolute lymphocyte count and peripheral blood lymphocyte subsets percentage with minimal residual disease at the end of induction in pediatric B cell acute lymphoblastic leukemia
    Pushpam, Deepam
    Rajput, Nishi
    Chopra, Anita
    Vishnubhatla, Sreenivas
    Kumari, Mamta
    Kumar, Rajive
    Bakhshi, Sameer
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (03) : 138 - 150
  • [26] Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia
    Le Jeune, Caroline
    Bertoli, Sarah
    Elhamri, Mohamed
    Vergez, Francois
    Borel, Cecile
    Huguet, Francoise
    Michallet, Mauricette
    Dumontet, Charles
    Recher, Christian
    Thomas, Xavier
    LEUKEMIA & LYMPHOMA, 2014, 55 (04) : 855 - 862
  • [27] Lack of Prognostic Significance of Monosomal Karyotype and Absolute Lymphocyte Count At Diagnosis in Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia
    Sirop, Saad J.
    Al-Kali, Aref
    Begna, Kebede
    Gangat, Naseema
    Letendre, Louis
    Porrata, Luis F.
    Hogan, William J.
    Litzow, Mark R.
    Patnaik, Mrinal M.
    BLOOD, 2012, 120 (21)
  • [28] EARLY ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR OF RELAPSE OR SURVIVAL IN ACUTE MYELOID LEUKEMIA
    Yamazaki, E.
    Yamamoto, E.
    Ogusa, E.
    Koyama, S.
    Yamamoto, W.
    Nakajima, Y.
    Ito, S.
    Motohashi, K.
    Hagihara, M.
    Matsumoto, K.
    Tanaka, M.
    Koharazawa, H.
    Tomita, N.
    Taguchi, J.
    Fujimaki, K.
    Fujita, H.
    Fujisawa, S.
    Kanamori, H.
    Ogawa, K.
    Ishigatsubo, Y.
    HAEMATOLOGICA, 2014, 99 : 31 - 31
  • [29] Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.
    Behl, D
    Porrata, LF
    Markovic, SN
    Elliott, MA
    Hook, CC
    Kaufman, SH
    Letendre, L
    Pruthi, RK
    Tefferi, A
    Litzow, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 573S - 573S
  • [30] Absolute Lymphocyte Count at the End of Induction as a Surrogate Marker for Minimal Residual Disease in T Acute Lymphoblastic Leukemia: A Pilot Study
    Pushpam, D.
    Chopra, A.
    Kumari, M.
    Sreenivas, V.
    Kumar, R.
    Bakhshi, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S153 - S153
12345